Electronic Lab Notebook from Dassault Systèmes BIOVIA serving 2,000+ customers including Pfizer, AstraZeneca, BASF, Shell. Supports both cloud and on-premises deployments with compliance features.
BIOVIA Notebook is an electronic lab notebook from Dassault Systèmes BIOVIA, serving over 2,000 customers across pharmaceutical companies including Pfizer and AstraZeneca, chemical companies including BASF and Shell, and consumer goods companies including Unilever and L Oreal.
The latest release, BIOVIA Notebook 2023 SP1, supports both cloud and on-premises deployments and adds features for data capture, collaboration, intellectual property protection, and regulatory compliance.
A Senior Scientist at NanoChem Solutions stated: "I like the product in terms of its ease of use, supporting both development and quality work." BIOVIA Notebook serves both R&D and quality control laboratories within pharmaceutical and life sciences organisations.
As part of the broader Dassault Systèmes 3DEXPERIENCE BIOVIA platform, the notebook integrates with other BIOVIA applications for scientific data management, laboratory informatics, and molecular modelling.
The platform includes electronic signatures, audit trails, and validation support for FDA-regulated pharmaceutical laboratories.
Pharmaceutical Edition
BIOVIA Notebook serves pharmaceutical, biotechnology, and chemical industries with specific focus on R&D and quality laboratories. Part of the broader BIOVIA laboratory informatics portfolio designed for life sciences and regulated industries requiring GxP compliance, validation support, and regulatory documentation.
Core Capabilities
FDA & GxP Compliance
Data Integrity & Validation
Part of Dassault Systèmes 3DEXPERIENCE platform. Cloud and on-premise deployment options available.
Pricing is undisclosed. The vendor provides custom quotes based on deployment size, modules selected, and organisational requirements.
Professional services available for implementation, validation support, and deployment.
Anonymous feedback from pharmaceutical professionals using this solution
3.9 out of 5
Based on 11 verified reviews
What Users Like
2,000+ customers, including named pharmaceutical customers Pfizer and AstraZeneca. The 2023 SP1 release added data capture and collaboration features. Cloud and on-premises deployment are both supported. A customer testimonial praises the product's ease of use, "supporting both development and quality work" (Senior Scientist, NanoChem Solutions). The platform integrates with the broader Dassault Systèmes 3DEXPERIENCE platform for scientific data management. It includes intellectual property protection and regulatory compliance features, and is part of the wider Dassault Systèmes portfolio.
What Users Dislike
Limited detailed customer reviews are available, which limits assessment of specific strengths and weaknesses from a user perspective. Gartner Peer Insights is referenced as a review source; specific ratings and user feedback are undisclosed. As part of the larger BIOVIA portfolio, realising full integration benefits may require adopting other BIOVIA applications, increasing overall investment. Implementation complexity and learning curve are undocumented in available customer testimonials.
Help the community
Share your experience with BIOVIA Notebook anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section